Cargando…

Isolation and characterization of circulating tumor cells in prostate cancer

Circulating tumor cells (CTCs) are tumor cells found in the peripheral blood that putatively originate from established sites of malignancy and likely have metastatic potential. Analysis of CTCs has demonstrated promise as a prognostic marker as well as a source of identifying potential targets for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diamond, Elan, Lee, Guang Yu, Akhtar, Naveed H., Kirby, Brian J., Giannakakou, Paraskevi, Tagawa, Scott T., Nanus, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2012
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468833/ https://www.ncbi.nlm.nih.gov/pubmed/23087897 http://dx.doi.org/10.3389/fonc.2012.00131

Ejemplares similares

Circulating Tumor Cells from Prostate Cancer Patients Interact with E-Selectin under Physiologic Blood Flow
por: Gakhar, Gunjan, et al.
Publicado: (2013)

Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device
por: Kirby, Brian J., et al.
Publicado: (2012)

Correction: Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device
por: Kirby, Brian J., et al.
Publicado: (2012)

Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer
por: Tagawa, Scott T., et al.
Publicado: (2013)

Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer
por: Armstrong, Andrew J., et al.
Publicado: (2020)

Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage
por: Gjyrezi, Ada, et al.
Publicado: (2021)

Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxel
por: Mukhtar, Eiman, et al.
Publicado: (2020)

ERG induces taxane resistance in castration-resistant prostate cancer
por: Galletti, Giuseppe, et al.
Publicado: (2014)

Prostate-Specific Membrane Antigen-Based Therapeutics
por: Akhtar, Naveed H., et al.
Publicado: (2012)

The Current Role of Androgen Deprivation in Patients Undergoing Dose-Escalated External Beam Radiation Therapy for Clinically Localized Prostate Cancer
por: Smith, Michael J., et al.
Publicado: (2012)

New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers
por: Ried, Karin, et al.
Publicado: (2020)

Review of Salvage Therapy for Biochemically Recurrent Prostate Cancer: The Role of Imaging and Rationale for Systemic Salvage Targeted Anti-Prostate-Specific Membrane Antigen Radioimmunotherapy
por: Kosuri, Satyajit, et al.
Publicado: (2012)

Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer
por: Lian, Shenyi, et al.
Publicado: (2021)

Characterizing the Genomic Landscape of Brain Glioma With Circulating Tumor DNA From Tumor In Situ Fluid
por: Sheng, Zhiyuan, et al.
Publicado: (2021)

The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype
por: Yu, Jing-Jing, et al.
Publicado: (2021)

Towards clinical implementation of circulating tumor DNA in metastatic prostate cancer: Opportunities for integration and pitfalls to interpretation
por: Kwan, Edmond M., et al.
Publicado: (2022)

AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer
por: Kim, Seaho, et al.
Publicado: (2022)

DNA repair deficiency as circulating biomarker in prostate cancer
por: Catalano, Martina, et al.
Publicado: (2023)

Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imaging
por: Yeo, Dannel, et al.
Publicado: (2023)

Circulating Tumor Cells for Glioma
por: Zhang, Huikai, et al.
Publicado: (2021)

Prostate preserving resection of a rare giant peri-prostatic solitary fibrous tumor
por: Gilbert, Brent, et al.
Publicado: (2020)

Characterization of proteins, mRNAs, and miRNAs of circulating extracellular vesicles from prostate cancer patients compared to healthy subjects
por: Chisholm, Jolene, et al.
Publicado: (2022)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

Characterization of 7-Methylguanosine Identified Biochemical Recurrence and Tumor Immune Microenvironment in Prostate Cancer
por: Xin, Sheng, et al.
Publicado: (2022)

Membrane Hsp70—A Novel Target for the Isolation of Circulating Tumor Cells After Epithelial-to-Mesenchymal Transition
por: Breuninger, Stephanie, et al.
Publicado: (2018)

Circulating Tumor Cells in Desmoid Tumors: New Perspectives
por: Braun, Alexcia C., et al.
Publicado: (2021)

Editorial: Molecular genetics and therapeutic advances in renal carcinoma
por: Nanus, David M., et al.
Publicado: (2023)

Circulating Tumor Cells: Back to the Future
por: Gallerani, Giulia, et al.
Publicado: (2017)

Mitochondria dysfunction in circulating tumor cells
por: Agnoletto, Chiara, et al.
Publicado: (2022)

Modeling and Simulation of Procoagulant Circulating Tumor Cells in Flow
por: Lee, Angela M., et al.
Publicado: (2012)

Clinical Significance of Mesenchymal Circulating Tumor Cells in Patients With Oligometastatic Hormone-Sensitive Prostate Cancer Who Underwent Cytoreductive Radical Prostatectomy
por: Yang, Guanjie, et al.
Publicado: (2022)

Pro-metastatic and mesenchymal gene expression signatures characterize circulating tumor cells of neuroblastoma patients with bone marrow metastases and relapse
por: Loh, Amos H. P., et al.
Publicado: (2022)

Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction
por: Bidarra, David, et al.
Publicado: (2019)

Circulating Cell-Free DNA-Based Detection of Tumor Suppressor Gene Copy Number Loss and Its Clinical Implication in Metastatic Prostate Cancer
por: Dong, Xiaoxi, et al.
Publicado: (2021)

Isolated brain metastasis of prostate carcinoma in the setting of normal prostate specific antigen
por: Campagna, Justin P., et al.
Publicado: (2018)

Circulating Tumor Cells: The Substrate of Personalized Medicine?
por: Greene, Bryan T., et al.
Publicado: (2012)

The Challenges of Detecting Circulating Tumor Cells in Sarcoma
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016)

Aneuploid subtypes of circulating tumor cells and circulating tumor-derived endothelial cells predict the overall survival of advanced lung cancer
por: Zhang, Jie, et al.
Publicado: (2023)

Isolated Hepatic Metastasis from Prostate Carcinoma
por: Wang, Stephani C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dcpi9qn0pc8k7aavddcc5i3mh3